Tagalogon, Morito .
HRN: 21-81-84 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/17/2022
CEFUROXIME 1.5GM (VIAL)
08/17/2022
08/23/2022
IVT
1.5gms
Q8
Uti, Cvd Bleed Left Mca
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes